Abstract: A display apparatus includes a display; a stand, and a control device. The stand includes a stand body and a bolt. The bolt may be configured to protrude from the stand body. The control device is electrically connectable to the display and includes a mounting hole on the side. The stand and the control device may be configured so that the bolt protruding from the stand body may be inserted into the mounting hole to mount the control device on the stand. The control device mounted on the stand is supported by the stand.

Abstract: An immune-proteomic screening of AAb responses using protein arrays has identified two panels of Aab (antigen/antibody complexes) that can potentially differentiate lung adenocarcinoma from smoker controls as well as CT positive benign lung disease. The resulting biomarkers appear to have high specificity so that high risk subjects with a positive CT screen and a positive serum test should get more invasive test such as needle biopsy for a timely cancer diagnosis, among other advantages.

Abstract: The present invention relates to a haptic feedback system, and in particular to a device and method for rapidly removing residual vibration in a linear resonant actuator, the method driving the linear resonant actuator by applying a resonant frequency thereto to implement a haptic function and applying a braking signal for removing the residual vibration after the driving of the linear resonant actuator, wherein the braking signal is a driving wave for generating the same vibration waveform as a residual vibration waveform of the linear resonant actuator, and is applied to the linear resonant actuator at a point of time when a BEMF signal of the linear resonant actuator crosses a zero point, the braking signal being applied in an opposite direction in which it is possible to cancel the residual vibration waveform of the linear resonant actuator.

Abstract: A method of implanting and securing an implantable flow connector in a body of a patient for providing communication of a first space within the body of the patient with a second space within the body of the patient. The method includes providing a flow connector having a lumen having a first orifice and a second orifice, inserting a retention device into the first space within the body, subsequently inserting the flow connector through an opening in the retention device so the second portion of the flow connector extends into the first space within the body and placing the second space within the body over the retention device.

Abstract: Disclosed herein are compositions and methods for accurately estimating the absorbed dose of radiation indicated by a subject based on the expression pattern of a panel of radiation-modulated (RM) genes at various time points following exposure of the subject to ionizing radiation.

Abstract: Cancer patients make antibodies to tumor-derived proteins that are potential biomarkers for early detection. Twenty-eight antigens have been identified as potential biomarkers for the early detection of basal-like breast cancer (Tables 1, 2). Also, a 13-AAb classifier has been developed that differentiate patients with BLBC from healthy controls with 33% sensitivity at 98% specificity (Table 3).

Abstract: The present invention pertains to a thrombectomy device comprising a cylindrical proximal portion, a dome-shaped distal portion, a transition portion, and a coil. The cylindrical proximal portion forms a stent frame having a first lattice network of a first plurality of interconnecting segments. The first plurality of interconnecting segments is configured to exert a first radial force against an inner wall of a blood vessel. The dome-shaped distal portion forms a protection cage having a second lattice network of a second plurality of interconnecting segments. The second plurality of interconnecting segments is configured to exert a second radial force against the inner wall of the blood vessel. The transition portion is arranged between the stent frame and the protection cage. The coil is formed at a distal end of the protection cage.

Abstract: Disclosed is a method of functional genomics determination including transducing a cell population with a set of nucleic acid molecules including a pooled library of genomic perturbagens to integrate multiple perturbagen cassettes into the genome. A phenotype of individual cells is determined and single cells of the population with targeted phenotypes are individually sorted into a set of compartments. Each compartment includes a forward primer with a nucleic acid sequence (NAS) that specifically binds a common nucleic acid sequence on the nucleic acid molecules and a compartment (cell)-specific nucleic acid barcode. Also included is a reverse primer with a NAS that specifically binds a common NAS on the nucleic acid molecules comprising a pooled library of genomic perturbagens. The genome-integrated perturbagen cassettes are create amplicons which are pooled and sequences determined.

Abstract: Cancer patients make antibodies to tumor-derived proteins that are potential biomarkers for early detection. Twenty-eight antigens have been identified as potential biomarkers for the early detection of basal-like breast cancer (Tables 1, 2). Also, a 13-AAb classifier has been developed that differentiate patients with BLBC from healthy controls with 33% sensitivity at 98% specificity (Table 3).

Abstract: A display apparatus including display panel, a rear case to cover a rear of the display panel and the rear case including a cable fixing hole to which a cable is fixed, a connector connected to the cable and fastened to the rear case so that the cable is connected to the rear case, a cable holder to surround a part of the cable and fixed to the cable fixing hole so that the cable is fixed to the rear case, and a clamp to fix the cable holder to the cable fixing hole, wherein the clamp includes a first hook to be fixed to the cable fixing hole, and a second hook having a different shape than a shape of the first hook and to be fixed to the cable fixing hole to have a greater fixing force than a fixing force of the first hook.

Abstract: A stent delivery system for in-situ deployment of a self-expanding stent is described. The stent delivery system includes a self-expanding stent retention sleeve and a pushwire disposed inside the self-expanding stent retention sleeve. The self-expanding stent retention sleeve includes a proximal end, a distal end, and a central section having a plurality of slots that form a plurality of struts in the central section. The distal end of the pushwire has at least one groove formed therein, which releasably couples with at least one protrusion formed at a proximal end of the self-expanding stent. The distal end of the self-expanding stent retention sleeve moves toward the proximal end of the self-expanding stent retention sleeve when the self-expanding stent retention sleeve is in an unconstrained configuration, thereby releasing the at least one protrusion from the at least one groove to deploy the self-expanding stent.

Abstract: A stent having a substantially tubular body is disclosed. In at least one embodiment, the stent provides a scaffold having a plurality of interconnected struts forming a plurality of radial axial rows of radial support cells and a plurality of flexible axial rows of flexible support cells. The plurality of radial axial rows and flexible axial rows are disposed in an alternating pattern along a circumferential axis of the stent. A center axis of each radial axial row and flexible axial row is parallel to a longitudinal axis of the stent. Each radial axial row is arranged so as to be offset along the longitudinal axis of the stent from each adjacent radial axial row. Each radial support cell is formed from four of the interconnected struts of the scaffold which are arranged so as to be symmetrical along both the longitudinal axis and the circumferential axis of the stent.

Abstract: The present invention relates autoantibody biomarkers, kits, and methods for increasing the accuracy of a cancer or autoimmune screening of a subject suspected of having cancer or an autoimmune condition.

Abstract: Provided herein are compositions comprising coordinated sets of unique DNA barcodes and methods for using the same for multiplex detection and measurement of multiple target molecules in multiple samples using a single next-generation sequencing reaction. In particular, methods are provided in which unique DNA barcodes linked to affinity reagents are contacted to a sample to bind antigens if present in said sample, and then a PCR-based amplification reaction adds barcoded index sequences that contain universal sequencing adaptors as well as unique barcode sequences and amplifies affinity reagent-bound targets for DNA sequencing.

Abstract: A stent device is described. The stent device includes a stent and a stent delivery system. The stent includes a cylindrical portion forming a stent frame having an outer lattice network of a plurality of interconnecting segments configured to exert a radial force against an inner wall of a blood vessel. The stent delivery system includes a locking mechanism configured to engage with the proximal end of the stent frame when covered in a sheath, and a push wire. The locking mechanism includes a proximal retention disk and a distal retention disk, the distal retention disk having a plurality of slots configured to engage with an equal plurality of struts formed on a proximal end of the stent.

Abstract: The present invention relates to a new type of current driving circuit, which has high linearity during low current driving, comprising: a voltage-current conversion unit for converting an input voltage into a current; a digital analog converter (DAC) connected to an output terminal of the voltage-current conversion unit and for generating and outputting a voltage corresponding to an applied digital code; a field effect transistor having a first electrode connected to a load and a second electrode connected to a node connected to a resistor, and for allowing a current to flow to the load in response to a voltage applied to a gate; an amplifier for receiving the voltage output from the digital analog converter and a voltage generated by the resistor, generating a voltage for controlling such that a current flows from the field effect transistor, and applying same to the gate; a current supply source for supplying to the first electrode a current required for operating the field effect transistor in a saturatio

Abstract: A method for providing a context awareness service is provided. The method includes defining a control command for the context awareness service depending on a user input, triggering a playback mode and the context awareness service in response to a user selection, receiving external audio through a microphone in the playback mode, determining whether the received audio corresponds to the control command, and executing a particular action assigned to the control command when the received audio corresponds to the control command.

Abstract: The present invention pertains to a thrombectomy device comprising a cylindrical proximal portion and one or more radiopaque segments. The cylindrical proximal portion forms a stent frame having an outer lattice network of an outer plurality of interconnecting segments. The outer plurality of interconnecting segments are configured to exert a radial force against an inner wall of a blood vessel. The radiopaque segment is formed from a plurality of radiopaque wires extending from the outer stent frame to a central axis of the thrombectomy device along a length of the stent frame. The radiopaque segment converges to a tip along with the central axis.

Abstract: The present invention relates to a haptic feedback system, and in particular to a device and method for rapidly removing residual vibration in a linear resonant actuator, the method driving the linear resonant actuator by applying a resonant frequency thereto to implement a haptic function and applying a braking signal for removing the residual vibration after the driving of the linear resonant actuator, wherein the braking signal is a driving wave for generating the same vibration waveform as a residual vibration waveform of the linear resonant actuator, and is applied to the linear resonant actuator at a point of time when a BEMF signal of the linear resonant actuator crosses a zero point, the braking signal being applied in an opposite direction in which it is possible to cancel the residual vibration waveform of the linear resonant actuator.